NCT06772194Recruiting
Taiwan Post-Stroke Disability Study
Taiwan Post-Stroke Disability Study (T-PODS): A Survey of Multiple Post-Stroke Disability Domains Among Stroke Patients in Taiwan
Source: ClinicalTrials.gov · Last updated 13 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Stroke remains a major health issue in Taiwan, being the fourth leading cause of death and the top cause of disability. While past research has focused on functional outcomes at three months post-stroke, stroke can cause a range of disabilities in areas such as motor function, swallowing, cognition, depression, and epilepsy. This study will investigate these disabilities by enrolling 2,000 acute stroke patients (both ischemic and hemorrhagic) from 10 medical centers across Taiwan. Data will be collected at three key points: at enrollment, three months, and twelve months post-stroke, using surveys, assessments, imaging, and blood samples. The aim is to examine the prevalence, risk factors, and long-term changes of post-stroke disabilities, ultimately seeking ways to reduce the health burden of stroke in Taiwan.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 2 Jan 2025
- Start date
- 21 Oct 2024
- Primary completion date
- 30 Sept 2028
- Lead sponsor
- National Taiwan University Hospital
- NCT number
- NCT06772194
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 21 Oct 2024 to the primary completion date, 30 Sept 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of clinical stroke within three months prior to enrollment.
- Severe dementia prior to the stroke.
Other illness
- Transient ischemic stroke and subarachnoid hemorrhage.
- Clear and severe psychiatric or emotional disorders before the stroke, including schizophrenia, major depressive disorder, and bipolar disorder.
- Pre-stroke modified Rankin Scale (mRS) score ≥ 3.
- Post-stroke mRS score of 5 at enrollment.
- History of cancer with an expected life expectancy of less than one year.
- Expected life expectancy of less than one year due to other medical conditions.
Other
- Unable to communicate or cooperate for assessments due to severe aphasia.
- Anticipated inability to complete a one-year follow-up.
- Other situations deemed unsuitable for enrollment by the clinical investigator.
Who the study is looking for
- Ischemic stroke confirmed by MRI, or hemorrhagic stroke diagnosed by CT or MRI.
- Age ≥ 18 years.
- Pre-stroke modified Rankin Scale (mRS) score of 0, 1, or 2.
- Post-stroke mRS score of 0, 1, 2, 3, or 4 at enrollment.
- Able to undergo cognitive function screening and other scale assessments within 30 days post-stroke.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Taiwan University Hospital, Taipei, Coordinator of this site? Confirm its status | Taipei | Taiwan | Recruiting |
Related publications
- Taiwan Poststroke Disability Study: A Study Protocol.Acta Neurol Taiwan · 2026 · PMID 42033805
This page is information, not medical advice. Discuss any trial with your doctor.